A comparative study to evaluate the efficacy and tolerability of new generations of iron preparations with traditional iron therapy in pediatrics: A prospective randomized controlled trial.

Menoufia faculty of medicine0 个研究点目标入组 87 人开始时间: 2024年2月19日最近更新: 2024年4月8日

适应症

试验速览

暂无简介。

•Age range 6 months till 59 months old
•no evidence of infection and negative c–reactive protein (CRP)
•hemoglobin below the WHO stipulated cutoff values to define IDA anemia: hemoglobin <11.0 g/dL, MCV <73 fL and serum ferritin < 12 mg/L.
•no history of consumption of iron supplements for 4 months ago or history of blood transfusion.

•Children who had any signs of infection (fever, vomiting or diarrhea) on blood collection days,
•children with anemia rather than IDA e.g. hemolytic anemia or haemoglobinopathy (sickle cell disease, beta thalassemia major)
•children with chronic diseases or drugs that may affect iron absorption

发起方

Menoufia faculty of medicine